Disease, Disability, and Injury Prevention and Control, 27797 [2010-11887]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 95 / Tuesday, May 18, 2010 / Notices
onto the NIH campus. All visitor vehicles,
including taxis, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://www.
nichd.nih.gov/about/nachhd.htm, where an
agenda and any additional information for
the meeting will be posted when available.
In order to facilitate public attendance at
the open session of Council, reserve seating
will be made available to the first five
individuals reserving seats in the main
meeting room, Conference Room 6. Please
contact Ms. Lisa Kaeser, Program and Public
Liaison Office, NICHD, at 301–496–0536 to
make your reservation. Additional seating
will be available in the meeting overflow
rooms, Conference Rooms 7 and 8.
Individuals will also be able to view the
meeting via NIH Videocast. Please go to the
following link for Videocast access
instructions at: https://wwwauthor.nichd.nih.
gov/about/overview/advisory/nachhd/virtualmeeting-201005.cfm. The meeting is partially
closed to the public.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment program, National
Institutes of Health, HHS)
Dated: May 12, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
Password: ACCV.
Agenda: The agenda items for the
December meeting will include, but are not
limited to: updates from the Division of
Vaccine Injury Compensation (DVIC),
Department of Justice, National Vaccine
Program Office, Immunization Safety Office
(Centers for Disease Control and Prevention),
National Institute of Allergy and Infectious
Diseases (National Institutes of Health), and
Center for Biologics, Evaluation and Research
(Food and Drug Administration). Agenda
items are subject to change as priorities
dictate.
Public Comments: Persons interested in
providing an oral presentation should submit
a written request, along with a copy of their
presentation to: Annie Herzog, DVIC,
Healthcare Systems Bureau (HSB), Health
Resources and Services Administration
(HRSA), Room 11C–26, 5600 Fishers Lane,
Rockville, Maryland 20857 or e-mail:
aherzog@hrsa.gov. Requests should contain
the name, address, telephone number, and
any business or professional affiliation of the
person desiring to make an oral presentation.
Groups having similar interests are requested
to combine their comments and present them
through a single representative. The
allocation of time may be adjusted to
accommodate the level of expressed interest.
DVIC will notify each presenter by mail or
telephone of their assigned presentation time.
Persons who do not file an advance request
for a presentation, but desire to make an oral
statement, may announce it at the time of the
comment period. These persons will be
allocated time as it permits.
FOR FURTHER INFORMATION CONTACT:
Anyone requiring information regarding
the ACCV should contact Annie Herzog,
DVIC, HSB, HRSA, Room 11C–26, 5600
Fishers Lane, Rockville, MD 20857;
telephone (301) 443–6593 or e-mail:
aherzog@hrsa.gov.
[FR Doc. 2010–11848 Filed 5–17–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: May 11, 2010.
Sahira Rafiullah,
Director, Division of Policy and Information
Coordination.
Health Resources and Services
Administration
[FR Doc. 2010–11837 Filed 5–17–10; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Times and Date: 11:30 a.m.–6:30 p.m.,
June 17, 2010 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5, U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Section 10(d)
of Public Law 92–463.
Matters To Be Discussed: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Prevention of Suicidal Behavior
through the Enhancement of
Connectedness (U01), RFA CE10–006’’.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Jane Suen, Dr.P.H., M.S., National
Center for Injury Prevention and
Control, Office of the Director,
Extramural Research Program Office,
4770 Buford Highway, NE., Mailstop F–
63, Atlanta, Georgia 30341, Telephone
(770) 488–4281.
The Director, Management Analysis
and Services Office has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both CDC and
the Agency for Toxic Substances and
Disease Registry.
Dated: May 11, 2010.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2010–11887 Filed 5–17–10; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4165–15–P
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), notice is hereby given
of the following meeting:
mstockstill on DSKH9S0YB1PROD with NOTICES
Advisory Commission on Childhood
Vaccines; Notice of Meeting
27797
Name: Advisory Commission on
Childhood Vaccines (ACCV).
Date and Time: June 10, 2010, 1 p.m. to
5:30 p.m. EDT; June 11, 2010, 9 a.m. to 12:30
p.m. EDT.
Place: Parklawn Building (and via audio
conference call), Conference Rooms G & H,
5600 Fishers Lane, Rockville, MD 20857.
The ACCV will meet on Thursday, June 10
from 1 pm to 5:30 pm (EDT) and Friday, June
11 from 9 a.m. to 12:30 p.m. (EDT). The
public can join the meeting via audio
conference call by dialing 1–888–849–8919
on June 10 & 11 and providing the following
information:
Leader’s Name: Dr. Geoffrey Evans.
VerDate Mar<15>2010
17:22 May 17, 2010
Jkt 220001
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control
Special Emphasis Panel (SEP):
Prevention of Suicidal Behavior through
the Enhancement of Connectedness
(U01), Request for Applications (RFA)
CE10–006, initial review.
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the aforementioned meeting:
PO 00000
Frm 00097
Fmt 4703
Sfmt 4703
Notice of Meeting
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Evaluation of
Offering and Documenting Influenza
Vaccination for Nursing Home
Residents, Funding Opportunity
Announcement (FOA) IP10–001;
Development, Implementation, and
Evaluation of a Multi-Component
Intervention to Vaccinate Adolescents at
Risk for Vaccine-Preventable Diseases,
FOA IP10–002; Evaluation and Impact
of a State Law Requiring Mandatory
Influenza Vaccination of Hospital
Employees, FOA IP10–003; and
Improving the Translation of the
E:\FR\FM\18MYN1.SGM
18MYN1
]]>Agencies
[Federal Register Volume 75, Number 95 (Tuesday, May 18, 2010)]
[Notices]
[Page 27797]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-11887]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control
Special Emphasis Panel (SEP): Prevention of Suicidal Behavior
through the Enhancement of Connectedness (U01), Request for
Applications (RFA) CE10-006, initial review.
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the aforementioned meeting:
Times and Date: 11:30 a.m.-6:30 p.m., June 17, 2010 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance with
provisions set forth in Section 552b(c)(4) and (6), Title 5, U.S.C.,
and the Determination of the Director, Management Analysis and Services
Office, CDC, pursuant to Section 10(d) of Public Law 92-463.
Matters To Be Discussed: The meeting will include the initial
review, discussion, and evaluation of applications received in response
to ``Prevention of Suicidal Behavior through the Enhancement of
Connectedness (U01), RFA CE10-006''.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Jane Suen, Dr.P.H., M.S.,
National Center for Injury Prevention and Control, Office of the
Director, Extramural Research Program Office, 4770 Buford Highway, NE.,
Mailstop F-63, Atlanta, Georgia 30341, Telephone (770) 488-4281.
The Director, Management Analysis and Services Office has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: May 11, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2010-11887 Filed 5-17-10; 8:45 am]
BILLING CODE 4163-18-P
